Do you ever notice that you feel more energized or alert when meeting new people and forming first impressions? Other times, a first meeting will rub you the wrong way and you may feel less attentive. If you've experienced one or both of these, you may wonder: What makes a good first impression? How do you know you want to become friends with someone? What information do we pay attention to when interacting with someone for the first time? Good questions! Neuroscience and psychology researchers wonder about the same things. Here at the Social Neuroscience and Health lab, we study how the brain and the immune system work together to influence our behaviors and experiences. The Friendship Pathways Study is a research project aiming to answer questions about how the brain and immune system communicate when meeting new people and forming friendships.

In this study, we want to learn more about the possible relationship between the University of North Carolina at Chapel Hill's undergraduate history students' political parties and their library usage. This paper aims to explore the question: does political affiliation of undergraduate history majors influence their use of the library? Interviews will be held with 10 students, from different sides of the political spectrum. Information gathered from interviews will be analyzed for similarities, differences, and patterns.

This study is comparing the effect of video game therapy versus standard physical therapy on outcomes for knee osteoarthritis (OA) patients. Patients with knee OA will be placed in either 8 weeks of standard physical therapy or 8 weeks of physical therapy using a video game at a UNC PT clinic. The cost of PT will be covered by the study.

In this study, we want to learn if there is a relationship between proficiency in a language and how a person reads and depends on certain word structure cues.

In this study, we want to interview the parent/caregiver who stayed behind when the 82nd Airborne Division deployed through the Immediate Reaction Force (IRF) in January 2020, August 2021, and February 2022. We would like to learn how parents/caregivers feel this experience affected their school-aged children (K-12). Our goal is to give a voice to families to share their experiences, and help determine what additional supports might help families with future IRF deployments.

Have you been diagnosed with Lateralized Oropharyngeal Cancer . If so, you may be able to take part in a research study looking at the safety by using a special imaging study called lymph node mapping (lymphatic mapping) Single Photon Emission Computed Tomography (SPECT-CT) compared to the usual treatment when radiotherapy is given .

Cyclophosphamide is a chemotherapy (chemo) drug often given after a transplant to prevent GvHD. We are doing this study to see if a lower dose of cyclophosphamide after transplant is safer, but just as effective. Cyclophosphamide can prevent GvHD, but it can also make you sick and more likely to get an infection. This study will look at how well a lower dose of cyclophosphamide works to reduce these side effects, while also preventing GvHD. This study does not include any new or untested drugs. The drugs and procedures in this study are standard for transplant.

We are testing out a device that collects physical function data among older adults who have multiple chronic conditions. We want to see if the device works efficiently and is user friendly.

The study treatment, finerenone, is being developed to help people who have long lasting kidney disease, also known as chronic kidney disease (CKD). It works by blocking a certain hormone called aldosterone that causes injury and inflammation in the heart and kidney which is known to play a role in CKD. In this study, the researchers want to learn if finerenone works the same way in kidney transplant recipients. Some subjects will receive the study drug and some will receive a placebo.

Do you have pancreatic ductal adenocarcinoma that has come back after receiving standard therapy? If so, you may be able to participate in this gene therapy research study to learn more about using you own modified immune cells as possible treatment.